Zhiming Cai

Shenzhen Xenotransplantation Medical Engineering Research and Development Center, First Affiliated Hospital of Shenzhen University, Shenzhen University School of Medicine, Shenzhen University Health Science Center

Affiliated withFirst Affiliated Hospital of Shenzhen University, Shenzhen University School of Medicine, Shenzhen University Health Science Center First Affiliated Hospital of Shenzhen University, Health Science Center First Affiliated Hospital of Shenzhen University, Shenzhen Second People's Hospital

Research Area

Biography

Zhiming Cai has not added Biography.
If you are Zhiming Cai and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 3	Year
Publication title Cited by 4	2019
Publication title Cited by 4	2020
Publication title Cited by 2	2021

Other Publications

Article	Year
Expression of methionine adenosyltransferase 2A in renal cell carcinomas and potential mechanism for kidney carcinogenesis. BMC cancer\| PubMed ID: 24636201	2014
Pyruvate-associated acid resistance in bacteria. Applied and environmental microbiology\| PubMed ID: 24795365	2014
Deficient human β-defensin 1 underlies male infertility associated with poor sperm motility and genital tract infection. Science translational medicine\| PubMed ID: 25122636	2014
Regulation of histone demethylase KDM6B by hypoxia-inducible factor-2α. Acta biochimica et biophysica Sinica\| PubMed ID: 25520177	2015
Synthetic artificial microRNAs targeting UCA1-MALAT1 or c-Myc inhibit malignant phenotypes of bladder cancer cells T24 and 5637. Molecular bioSystems\| PubMed ID: 25800227	2015
The potential of the combination of CRISPR/Cas9 and pluripotent stem cells to provide human organs from chimaeric pigs. International journal of molecular sciences\| PubMed ID: 25807262	2015
Inducing cell growth arrest and apoptosis by silencing long non-coding RNA PCAT-1 in human bladder cancer. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine\| PubMed ID: 25934337	2015
A conjugate of octamer-binding transcription factor 4 and toll-like receptor 7 agonist prevents the growth and metastasis of testis embryonic carcinoma. Journal of translational medicine\| PubMed ID: 25990580	2015
GlnR-Mediated Regulation of ectABCD Transcription Expands the Role of the GlnR Regulon to Osmotic Stress Management. Journal of bacteriology\| PubMed ID: 26170409	2015
A functional variant in the UBE2B gene promoter is associated with idiopathic azoospermia. Reproductive biology and endocrinology : RB&E\| PubMed ID: 26223869	2015
Synthetic Tet-inducible small hairpin RNAs targeting hTERT or Bcl-2 inhibit malignant phenotypes of bladder cancer T24 and 5637 cells. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine\| PubMed ID: 26427661	2016
The Golgi-Associated Plant Pathogenesis-Related Protein GAPR-1 Enhances Type I Interferon Signaling Pathway in Response to Toll-Like Receptor 4. Inflammation\| PubMed ID: 26678074	2016
Tetracycline-inducible shRNA targeting antisense long non-coding RNA HIF1A-AS2 represses the malignant phenotypes of bladder cancer. Cancer letters\| PubMed ID: 27018306	2016
Circulating Organ-Specific MicroRNAs Serve as Biomarkers in Organ-Specific Diseases: Implications for Organ Allo- and Xeno-Transplantation. International journal of molecular sciences\| PubMed ID: 27490531	2016
EGCG inhibited bladder cancer SW780 cell proliferation and migration both in vitro and in vivo via down-regulation of NF-κB and MMP-9. The Journal of nutritional biochemistry\| PubMed ID: 28040581	2017
Synthetic artificial "long non-coding RNAs" targeting oncogenic microRNAs and transcriptional factors inhibit malignant phenotypes of bladder cancer cells. Cancer letters\| PubMed ID: 29501702	2018
Lentivirus-mediated shRNA targeting inhibits malignant phenotypes of bladder cancer SW780 cells. OncoTargets and therapy\| PubMed ID: 30275714	2018
Extracellular matrix protein 1 (ECM1) is associated with carcinogenesis potential of human bladder cancer. OncoTargets and therapy\| PubMed ID: 30863109	2019
LincRNA-p21 suppresses glutamine catabolism and bladder cancer cell growth through inhibiting glutaminase expression. Bioscience reports\| PubMed ID: 30902882	2019
Modulation of SRSF2 expression reverses the exhaustion of TILs via the epigenetic regulation of immune checkpoint molecules. Cellular and molecular life sciences : CMLS\| PubMed ID: 31838573	2020
Recurrent ZNF83-E293V Mutation Promotes Bladder Cancer Progression through the NF-κB Pathway via Transcriptional Dysregulation of S100A8. Molecular therapy : the journal of the American Society of Gene Therapy\| PubMed ID: 33002420	2021